Annual Working Capital
-$2.48 M
-$17.48 M-116.56%
December 31, 2023
Summary
- As of February 8, 2025, CLRB annual working capital is -$2.48 million, with the most recent change of -$17.48 million (-116.56%) on December 31, 2023.
- During the last 3 years, CLRB annual working capital has fallen by -$56.86 million (-104.57%).
- CLRB annual working capital is now -104.57% below its all-time high of $54.38 million, reached on December 31, 2020.
Performance
CLRB Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$15.58 M
+$2.85 M+22.36%
September 30, 2024
Summary
- As of February 8, 2025, CLRB quarterly working capital is $15.58 million, with the most recent change of +$2.85 million (+22.36%) on September 30, 2024.
- Over the past year, CLRB quarterly working capital has increased by +$30.49 million (+204.56%).
- CLRB quarterly working capital is now -71.34% below its all-time high of $54.38 million, reached on December 31, 2020.
Performance
CLRB Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
CLRB Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -116.6% | +204.6% |
| 3 y3 years | -104.6% | -59.2% |
| 5 y5 years | -120.2% | +32.4% |
CLRB Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -107.6% | at low | -52.2% | +204.6% |
| 5 y | 5-year | -104.6% | at low | -71.3% | +204.6% |
| alltime | all time | -104.6% | +69.3% | -71.3% | +204.6% |
Cellectar Biosciences Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $15.58 M(+22.4%) |
| Jun 2024 | - | $12.74 M(-49.3%) |
| Mar 2024 | - | $25.10 M(-268.4%) |
| Dec 2023 | -$2.48 M(-116.6%) | -$14.91 M(-509.6%) |
| Sep 2023 | - | $3.64 M(-535.5%) |
| Jun 2023 | - | -$835.60 K(-112.1%) |
| Mar 2023 | - | $6.89 M(-23.7%) |
| Dec 2022 | $15.00 M(-54.0%) | $9.03 M(-26.3%) |
| Sep 2022 | - | $12.25 M(-37.8%) |
| Jun 2022 | - | $19.68 M(-26.4%) |
| Mar 2022 | - | $26.74 M(-17.9%) |
| Dec 2021 | $32.58 M(-40.1%) | $32.58 M(-14.8%) |
| Sep 2021 | - | $38.23 M(-12.3%) |
| Jun 2021 | - | $43.61 M(-11.7%) |
| Mar 2021 | - | $49.38 M(-9.2%) |
| Dec 2020 | $54.38 M(+531.1%) | $54.38 M(+243.1%) |
| Sep 2020 | - | $15.85 M(-19.7%) |
| Jun 2020 | - | $19.72 M(+309.8%) |
| Mar 2020 | - | $4.81 M(-44.1%) |
| Dec 2019 | $8.62 M(-30.1%) | $8.62 M(-26.8%) |
| Sep 2019 | - | $11.77 M(-24.1%) |
| Jun 2019 | - | $15.51 M(+74.4%) |
| Mar 2019 | - | $8.89 M(-27.9%) |
| Dec 2018 | $12.33 M(+47.5%) | $12.33 M(-14.7%) |
| Sep 2018 | - | $14.45 M(+430.0%) |
| Jun 2018 | - | $2.73 M(-50.8%) |
| Mar 2018 | - | $5.54 M(-33.8%) |
| Dec 2017 | $8.36 M(-20.8%) | $8.36 M(+83.5%) |
| Sep 2017 | - | $4.55 M(-41.2%) |
| Jun 2017 | - | $7.75 M(-28.2%) |
| Mar 2017 | - | $10.79 M(+2.2%) |
| Dec 2016 | $10.56 M(-793.7%) | $10.56 M(+124.1%) |
| Sep 2016 | - | $4.71 M(-30.1%) |
| Jun 2016 | - | $6.75 M(-1288.4%) |
| Mar 2016 | - | -$567.60 K(-62.7%) |
| Dec 2015 | -$1.52 M(-143.9%) | -$1.52 M(-39.2%) |
| Sep 2015 | - | -$2.50 M(+200.5%) |
| Jun 2015 | - | -$832.90 K(-161.2%) |
| Mar 2015 | - | $1.36 M(-60.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $3.47 M(-297.4%) | $3.47 M(-64.8%) |
| Sep 2014 | - | $9.86 M(-578.1%) |
| Jun 2014 | - | -$2.06 M(+520.2%) |
| Mar 2014 | - | -$332.40 K(-81.1%) |
| Dec 2013 | -$1.76 M(-139.9%) | -$1.76 M(-302.8%) |
| Sep 2013 | - | $865.60 K(-1535.5%) |
| Jun 2013 | - | -$60.30 K(-104.0%) |
| Mar 2013 | - | $1.52 M(-65.5%) |
| Dec 2012 | $4.40 M(-17.2%) | $4.40 M(-16.3%) |
| Sep 2012 | - | $5.25 M(-21.7%) |
| Jun 2012 | - | $6.70 M(+90.5%) |
| Mar 2012 | - | $3.52 M(-33.7%) |
| Dec 2011 | $5.31 M(+1316.6%) | $5.31 M(+234.8%) |
| Sep 2011 | - | $1.59 M(-47.6%) |
| Jun 2011 | - | $3.03 M(+372.4%) |
| Mar 2011 | - | $641.40 K(+71.0%) |
| Dec 2010 | $375.00 K(-104.6%) | $375.00 K(-112.9%) |
| Sep 2010 | - | -$2.90 M(+46.7%) |
| Jun 2010 | - | -$1.98 M(+1806.1%) |
| Mar 2010 | - | -$103.70 K(-98.7%) |
| Dec 2009 | -$8.10 M(+54.9%) | -$8.10 M(+446.4%) |
| Sep 2009 | - | -$1.48 M(-55.4%) |
| Jun 2009 | - | -$3.32 M(-256.6%) |
| Mar 2009 | - | $2.12 M(-140.6%) |
| Dec 2008 | -$5.22 M(-230.6%) | -$5.22 M(+104.2%) |
| Sep 2008 | - | -$2.56 M(+0.8%) |
| Jun 2008 | - | -$2.54 M(-14.4%) |
| Mar 2008 | - | -$2.97 M(-174.1%) |
| Dec 2007 | $4.00 M(-62.2%) | $4.00 M(-63.2%) |
| Sep 2007 | - | $10.87 M(-38.2%) |
| Jun 2007 | - | $17.58 M(+112.0%) |
| Mar 2007 | - | $8.29 M(-21.6%) |
| Dec 2006 | $10.58 M(+130.7%) | $10.58 M(-19.8%) |
| Sep 2006 | - | $13.19 M(-17.2%) |
| Jun 2006 | - | $15.93 M(-8.2%) |
| Mar 2006 | - | $17.35 M(+278.3%) |
| Dec 2005 | $4.58 M | $4.58 M(-7.6%) |
| Sep 2005 | - | $4.96 M(+330.2%) |
| Jun 2005 | - | $1.15 M(-1110.2%) |
| Mar 2005 | - | -$114.20 K |
FAQ
- What is Cellectar Biosciences annual working capital?
- What is the all time high annual working capital for Cellectar Biosciences?
- What is Cellectar Biosciences annual working capital year-on-year change?
- What is Cellectar Biosciences quarterly working capital?
- What is the all time high quarterly working capital for Cellectar Biosciences?
- What is Cellectar Biosciences quarterly working capital year-on-year change?
What is Cellectar Biosciences annual working capital?
The current annual working capital of CLRB is -$2.48 M
What is the all time high annual working capital for Cellectar Biosciences?
Cellectar Biosciences all-time high annual working capital is $54.38 M
What is Cellectar Biosciences annual working capital year-on-year change?
Over the past year, CLRB annual working capital has changed by -$17.48 M (-116.56%)
What is Cellectar Biosciences quarterly working capital?
The current quarterly working capital of CLRB is $15.58 M
What is the all time high quarterly working capital for Cellectar Biosciences?
Cellectar Biosciences all-time high quarterly working capital is $54.38 M
What is Cellectar Biosciences quarterly working capital year-on-year change?
Over the past year, CLRB quarterly working capital has changed by +$30.49 M (+204.56%)